Table of Contents

CONTINUUM: Lifelong Learning in Neurology:
doi: 10.1212/01.CON.0000433297.91703.09
Table of Contents

    Multiple Sclerosis

    Guest Editors: Robert J. Fox, MD, FAAN; Alexander D. Rae-Grant, MD, FRCP(C)

    Editor’s Preface . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 899

    REVIEW ARTICLES

    Pathology of Multiple Sclerosis: Where Do We Stand? . . . . . . . . . . . . . . . . . . . . 901

    Bogdan F. Gh. Popescu, MD, PhD; Istvan Pirko, MD, FAAN; Claudia F. Lucchinetti, MD, FAAN

    Diagnosis and Differential Diagnosis of Multiple Sclerosis . . . . . . . . . . . . . . . . . 922

    Ilana B. Katz Sand, MD; Fred D. Lublin, MD, FAAN, FANA

    Acute Disseminated Encephalomyelitis, Transverse Myelitis, and Neuromyelitis Optica . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 944

    Dean M. Wingerchuk, MD, MSc, FRCP(C), FAAN; Brian G. Weinshenker, MD, FRCP(C), FAAN

    Present and Emerging Therapies for Multiple Sclerosis . . . . . . . . . . . . . . . . . . . 968

    Mark S. Freedman, MSc, MD, FAAN, FANA, FRCP(C)

    Unusual Symptoms and Syndromes in Multiple Sclerosis . . . . . . . . . . . . . . . . . 992

    Alexander D. Rae-Grant, MD, FRCP(C)

    Gait Disorders in Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1007

    Francois Bethoux, MD

    Pediatric Demyelinating Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1023

    Tanuja Chitnis, MD

    General Health Issues in Multiple Sclerosis: Comorbidities, Secondary Conditions, and Health Behaviors . . . . . . . . . . . . . . . . . . . . . . . . . . . 1046

    Ruth Ann Marrie, MD, PhD; Heather Hanwell, PhD

    Current and New Directions in MRI in Multiple Sclerosis . . . . . . . . . . . . . . . . . 1058

    Eric C. Klawiter, MD, MSc

    Optic Neuritis and the Evaluation of Visual Impairment in Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1074

    Robert A. Bermel, MD; Laura J. Balcer, MD, MSCE, FAAN

    ETHICAL PERSPECTIVES

    Disclosing a Misdiagnosis of Multiple Sclerosis: Do No Harm?. . . . . . . . . . . . 1087

    Andrew J. Solomon, MD; Eran Klein, MD, PhD

    PRACTICE ISSUES

    Multiple Sclerosis Treatment: Risk Mitigation . . . . . . . . . . . . . . . . . . . . . . . . . . . 1092

    Daniel Ontaneda, MD, MS; Robert J. Fox, MD, FAAN

    Special Considerations When Coding for Patients With Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1100

    Todd J. Janus, PhD, MD, FAAN

    Learning Objectives. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 891

    SELF-ASSESSMENT

    Instructions for Completing the Self-Assessment Pretest and Tally Sheet . . . . . 893

    Self-Assessment Pretest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 895

    CME

    Instructions for Completing CME and Tally Sheet. . . . . . . . . . . . . . . . . . . . . . . . 1107

    Multiple-Choice Questions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1109

    Multiple-Choice Questions-Preferred Responses . . . . . . . . . . . . . . . . . . . . . . 1122

    Patient Management Problem . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1144

    Patient Management Problem-Preferred Responses . . . . . . . . . . . . . . . . . . . 1149

    Robert J. Fox, MD, FAAN; Alexander D. Rae-Grant, MD, FRCP(C)

    Index. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1158

    List of Abbreviations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Back Cover

    ERRATUM

    Biomarkers of Alzheimer Disease: Current and Future Applications to Diagnostic Criteria: Erratum. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 892

    © 2013 American Academy of Neurology